Abstract
We consider the structure of the novel coronavirus (SARS-Cov-2) in terms of the number of spikes that are critical in bonding with the cells in the host. Bonding formation is considered for selection criteria with and without any treatments. Functional mappings from the discrete space of spikes and cells and their analysis are performed. We found that careful mathematical constructions help in understanding the treatment impacts, and the role of vaccines within a host. Smale's famous 2-D horseshoe examples inspired us to create 3-D visualizations and understand the topological diffusion of spikes from one human organ to another organ. The pharma industry will benefit from such an analysis for designing efficient treatment and vaccine strategies.
Keywords: COVID-19, Functional mapping, Host cells, Bonding, Vaccines, 3D horseshoe mapping
1. Introduction
The structure of the virus and spikes of the novel coronavirus (SARS-CoV-2 or COVID-19) that caused the suffering during 2020-2021 is understood in this article through topological constructions. We showed how such careful visualizations help to understand the virus-cell bonding through the distribution of spikes of the SARS-CoV-2. In general, the number of spikes and distribution of the spikes across various virus particles is found to be key in the spread of SARS-CoV-2 [4], [10], bonding of the spikes [2], [7], [11], [32], and in understanding the entry of the virus into key organs like the lungs [1], [3], [29], [31]. We found that such a detailed mathematical analysis will eventually assist in the careful design of vaccines and medicines. Several studies analyze the situations of inactivity of the SARS-CoV-2 and the role played by the spikes [8], [9], [16], [19], [20], [28].
Many experimental results on the spikes and their activation, bonding, and inactivation assisted in vaccine development [5], [14], [30]. The pharmaceutical and the vaccine industry would benefit from such detailed visualizations of internal structures and bonding, rate of unbonding, and the role of interventions [6], [12], [13], [23]. There are mathematical models in COVID-19 that were developed for assisting in designing pharmaceutical experiments [17].
In spite of experimental success in identifying a set of vaccine candidates for SARS-CoV-2 and the activity of the spikes, there exist several uncertainties in measuring successful vaccine impact. Theoretically, if a spike is completely bonded by an infected cell and this bonding is executed perfectly then that should lead to a new virus. At the same time, preventing a successful bonding and breaking of the spike would leave the virus incapable of spreading. Experiments leading to the identification of spike structures and their activities need to be more accurate and our present theoretical analysis promises to be useful for assisting in the experiments. Pharmaceutical and vaccination industries need to conduct highly accurate laboratory experiments. These experiments would need to carefully understand the role played by the spikes in SARS-CoV-2. Vaccines are designed to destroy the bonding capacity of these spikes or even destroy the spikes. Mathematical mapping, identification, and analysis of the spikes responsible for virus production within a host that are analyzed in this article are highly insightful for such experiments.
Our article will assist in improved design of vaccine experiments and better treatment designs that can take care of all the spikes at the time of entry into a host. Topological analysis is a rich tool and proper usage of it can help in avoiding uncertainties.
In this article, we have considered the following four assumptions in our topological constructions of the SARS-CoV-2:
-
(i)
Not all virus particles in the host are participating in infecting cells;
-
(ii)
Not all the spikes in a single virus may be bonded with cells;
-
(iii)
Each spike within a virus will bond with one and only cell;
-
(iv)
An empty spike (uninfected spike) of a given virus particle can bond with another cell.
This work provides original applications of topology which is one of the powerful tools of mathematical analysis [15], [18], [22], [25]. We cite here general references for the basic ideas of point-set topology. But our discrete constructions in this article are not explained in those sources. In the next section, we have described the basic topological space that we define using the number of spikes per virus particle within a host. We have provided novel usage of the mathematical analysis principles and topological constructions. A fraction of the spikes within a host in the space is allowed to get bonding with the uninfected cells. The entire structure of the space is mapped so that we can better understand the role of bonded and unbonded spikes within a host. After all, the infected cells and spikes are the carriers of the infected material to uninfected cells, so exact mapping and identification of their location within a host are central for understanding the vaccine efficacy. So a topological analysis will assist in targeted treatments and formulating within the host strategy of introducing a vaccination. Section 3 studies the role of treatment and vaccines in prohibiting the bonding and eliminating the infected host.
2. Topological structures
Overall structure and topology of the virus and bonding/unbonding by cells within the host are described through Fig. 2.2. Let be the novel coronavirus (ç) particle within a host at time that has j number of spikes. We choose and . Each of the spikes within the host is uniquely identified by this structure because is the distinct set of spikes of the first virus particle and so on. In general, is the distinct set of spikes of the -virus particle for . Such a construction also allows us to write the expression:
(2.1) |
Fig. 2.2.
Topology of novel coronavirus (SARS-CoV-2), spikes, bonding, reduction in virus bonding due to treatment. (a) Imaginative description of the SARS-CoV-2, spikes and host cells, (b) Bonding of spikes to host cells, reduction of viral load due to treatment.
The quantity in (2.1) represents the total spikes in the host which are ready to bond with cells within the host. The spikes in the expression (2.1) are not yet bonded. Let be the collection of all the spikes which were not yet bonded at time . Then
(2.2) |
Let be the fraction of the spikes in the -virus particle which are bonded with uninfected cells at time . The quantity indicates that the virus particle is fully bonded with uninfected cells, and each of the spikes is occupied in bonding. The quantity indicates that some of the spikes out of spikes in the virus particle are unoccupied (or empty). We write
where is the total number of spikes in which are bonded with uninfected cells at time . The cardinality of the set is
When for all i, then and when for at least one i, then . Suppose that , where consists of the set of all spikes both bonded and unbonded. The number of spikes that were bonded during is and is the number of spikes at which are not bonded with uninfected cells for . We assume an occupied spike with an uninfected cell will not be available for further bonding. So the bonded spikes at , i.e., , have completed their virus bonding capacity by time , and the remaining spikes available at time are . These unbonded spikes will be available for bonding during . Let be the bonded spike at time out of spikes at time for such that
(2.3) |
The number of occupied spikes among all the virus particles during which will not be available for further bonding are
If for any i at time then that virus particle has completed the bonding role in the system. It is assumed that number of spikes for each i (when would generate number of new virus particles available for bonding during , else (when ) it would generate number of new virus particles during the same period. See Fig. 2.1 .
Fig. 2.1.
Mapping of spikes in the ith virus particle at time t0 to bonded and unbonded spikes at time t1.
Hence the newer virus particles produced during are , so the available virus particles for bonding at time will be
(2.4) |
The birth rate (w.r.t. n) of the new virus particles during is
(2.5) |
Not all of the new viruses at time in (2.4) may be available for bonding during if one or more of the virus particles (out of n) might have all its spikes bonded at time .
Suppose that for () and for , such that
(2.6) |
Based on (2.6), the number of virus particles available at time after removing completely bonded virus particles during (i.e., those virus particles for which all of its spikes were bonded with uninfected cells, and adding new virus particles created by the virus particles with available spikes for bonding during ) are
(2.7) |
The total number of bonded spikes due to and are
(2.8) |
and, from (2.3),
(2.9) |
Let us decompose as
(2.10) |
where and .
The total bonded during is responsible for giving birth to new viruses as described previously. The total number of remaining spikes, those which are available at time , are the sum of (i) the number of spikes unbonded during , and (ii) the number of spikes that are created due to the birth of new virus particles. The listing of the set of spikes helps in constructing the function . Here is the set of spikes created by during . Let us list the elements of the set below:
The list of unbounded spikes during is obtained as remaining spikes from the first term of (2.9) as
(2.11) |
The list of spikes available at because of the first term of the R.H.S. of (2.10) is
(2.12) |
where the in (2.12) represent the spike of the virus resulting from in (2.10). That is, as per the set in (2.12), there are number of spikes for the first virus, number of spikes for the second virus, and so on spikes for the virus. The list of spikes available at due to the resultant of the second term of the R.H.S. of (2.10) is
(2.13) |
where the in (2.13) represent the spike of virus resulting out of in (2.10). That is, as per the set in (2.13), there are number of spikes for the first virus, number of spikes for the second virus, and so on spikes for the virus. The domain of the function will have the collection of all the elements of the sets and , i.e.
(2.14) |
The collections and constructed above can be treated as two spaces and in (2.14) is now seen as a disconnected space.
Lemma 1
The functionis not 1–1 when bonding occurs during .
Proof
We have , where and are the sets of all the distinct spikes at time and time . When bonding occurs during , the set of all spikes at time will be as seen in (2.14). This implies that
From (2.11) to (2.13) we can write
(2.15) Because of the inequality (2.15), cannot be 1–1. □
Corollary 2
The functionis 1–1 when no bonding occurs during . When the bonding does not occur then and the elements of and are not different.
Since we can consider
and the elements of are distinct, we treat here as a discrete topological space with elements in the space . Let and be two subsets of such that represents bonded spikes and represents unbonded spikes during . Then, by the construction of , the two subsets and form two disjoint subspaces of . The space as well is a discrete topological space and three subsets of it and , form three disjoint topological discrete subspaces of .
Definition 3 Topological diffusion —
We define here the topological diffusion of the space created due to newer spikes during , as
(2.16)
Theorem 4
The topological diffusion during is .
Proof
We have
(2.17) The set indicates the newer elements created in the combined space . The collection of elements of and in (2.17) are further expressed using (2.14) as follows:
□
The collection is the newer space created during .
Example 5
Suppose has 10 spikes. The topological diffusion occurred during to arrive at . See Fig. 2.3 for mapping of bonded cells into new spikes and carrying forward the unbonded spikes.
Fig. 2.3.
Numerical example of mapping of bonded and unbonded spikes. A1 ∪ B1 = 16 as shown is the topological diffusion of the space.
Every singleton set within is an open subset. That means that each spike in is considered as a singleton set and and form two open subsets of . In fact, according to discrete topology and can also be treated as closed subsets (so the space is disconnected). The transformations of the space during would lead to newer spaces due to bonding (also argued as in the proof of Lemma 1). Such a creation of new topological spaces and their cardinality can be influenced with a treatment intervention at some time t for . Treatment works in reducing the value of or the death rates of the virus particles or both.
3. Treatment and vaccinations
We assume a treatment to kill the virus population (viral load within a host) would increase the mortality rate of the virus population and reduce the bonding of the uninfected cell population with SARS-CoV-2. At time the viral load would be lower and treatment during would have a higher impact on reducing the viral load than if the treatment was introduced during . We assume a longer time to introduce a treatment after time according to the longer time the virus population is restricting the virus growth. Since in the absence of treatment, can be achieved (Corollary 2) when treatments are introduced during . We assume the host will be dominated by the virus when virus growth is not controlled and the virus will be eliminated either naturally or due to treatment impact. Let be defined as earlier and let be the fraction of the spikes in the virus which are bonded during and treatment was introduced at some time s for . Here, . The quantity means there are no bonded spikes at s. The quantity would never reach . Since the treatment would also increase the mortality rate of the population, we assume that if virus dies at s for or if no bonding with the spikes of the virus occurs. When , then all the spikes of the virus at will be available for bonding during .
Theorem 6
Consider the sequence of functions, where. Suppose a treatment is introduced atfor some. Then the sizes ofare increasing untiland the sizes ofare decreasing untiland(empty set).
Proof
When treatment prohibits bonding then virus population having no host would eventually die. Treatment would also kill bonded cells with spikes. Suppose the treatment is introduced at time s for and
The time intervals were partitioned as . Given that , we assume impact of the treatment can be measured in prohibiting the bonding at for . Similarly the treatment would have impact on killing the bonded cells with spikes at . Hence
(3.1) and
(3.2) The sequence in (3.2) is monotonic and for all . Hence, by the monotone convergence theorem, the sequence (3.2) is convergent to ϕ (empty set). □
Theorem 7
Consider the sequence of functions , where . Suppose the host is vaccinated prior to . Then the sequence is decreasing and .
Proof
Given for all n. When the host is vaccinated prior to the system will prohibit the spikes to get bonded with cells. Unbounded spikes and virus particles dying over time lead to the decreasing sequence
(3.3) Similar to the argument of the proof of the Theorem 6, we have
(3.4) □
Remark 8
A vaccinated host would alter the range of in Example 5 but the domain of consisting of vaccinated and not vaccinated hosts remains the same. COVID-19 vaccinations would not prevent virus to enter an unprotected host, but a vaccinated host prevents the virus from getting bonded with the virus spikes.
Given Theorem 7, this sequence of inequalities will emerge:
Since (3.4) is true, we will have
Here for is the remaining number of spikes unbounded during for . We can create the elements similar to (2.11) to (2.13) for the periods . Let , , be the sets defined on the intervals similar to , , which were defined from (2.11) to (2.13) for the elements defined on the interval . The topological diffusion created until the treatment initiated at is . Hence the diffusion of the elements created will start declining with the initiation of the treatment. The smaller the value of , the lesser the quantity .
Theorem 9
Topological structures of the virus populations and spikes will be different under vaccination and treatment of hosts even though.
Proof
Suppose the treatment is initiated within a host at for . The topological structure of spikes would first have the increasing property in (3.1), and then will start decreasing as in (3.2). This leads to .
Under a vaccinated host, as soon as the SARS-CoV-2 virus enters at , the topological structure of the spike population spread within the host obeys (3.3), and that leads to .
Hence, two topological structures described above will be different although the limiting number of spikes diminishes. □
3.1. Horseshoe mapping
Inspired by Stephen Smale's original famous horseshoe example [21], [24], [26], [27], we have visualized a discretized version of the same idea with plastic beads in a container. Let us consider a hollow cube and fill it with plastic beads. Suppose all the beads in this cube are transferred into a horseshoe-shaped pipe. See Fig. 3.1 . Note that the original horseshoe mapping is continuous and is a diffeomorphism between a square and horseshoe-shaped space. Let us imagine the size of the SARS-CoV-2 spikes are located in the throat area of a human host. Suppose during the interval these spikes are spread into the lung area. Assume that the treatment to control the virus is initiated at such that the throat area spikes are eliminated during and the number of spikes at , is the set . This leads to
Fig. 3.1.
Transformation of a cube containing beads into a horseshoe-shaped pipe containing the same number of beads. (a) A cube container of green color beads, (b) Beads in (a) are transferred into a horseshoe shaped pipe. The number of beads in (a) and (b) are equal. The beads in (b) can be transferred into (a). The beads occupying capacities of containers in (a) and (b) are equal and it is assumed that no free space left to add an additional bead into these containers. The original example of Stephen Smale is a diffeomorphism between two 2-D objects, namely, a square and a horseshoe, famously known as Smale's horseshoe. (For interpretation of the colors in the figure(s), the reader is referred to the web version of this article.)
Transformation of the number of spikes of in the throat area into number of spikes of lungs area is demonstrated in Fig. 3.2 . Suppose the size of the spikes at are located in the throat area of a host. We have . Under the no treatment assumption during , we have , where . The newer space created during is
(3.5) |
Fig. 3.2.
Transformation of the number of spikes at t1 in the throat area into the number of spikes at t3 in the lungs area. (a) The number of spikes in the throat at t1 are S(t1) and no infection in lungs, (b) The number of spikes grown during (t1,t2] expanded into lungs and treatment is introduced at t2, (c) The spikes in the throat are killed and the number of spikes at t3 in the lungs are S(t3) and .
The topological diffusion in (3.5) gives us,
Suppose the treatment for SARS-CoV-2 is introduced at such that
(3.6) |
is attained. There are now three possibilities that will arise due to (3.6):
Above possibility (ii) we associate with that of Smale's horseshoe type of example and is also demonstrated in Fig. 3.2. During the number of spikes killed in the throat due to the treatment initiated at and due to the creation of the topological diffusion reaches the size at . Then this kind of discrete topological transformation of the number of spikes at into the number of spikes at in a different location of a host is topologically visualized as an horseshoe type of example. Of course, we are aware in a true sense Smale's horseshoe is a diffeomorphism between two open spaces (a square and a horseshoe). The current analysis of transformations of the number of spikes located at in the throat area and the number of spikes at in the lungs within a host handles the points (elements) of the space discretely.
The horseshoe example transforms the points of an open square into an equivalent area horseshoe using continuous mapping. The implications of the horseshoe are plenty—for example, the squeezing and stretching of a square to a horseshoe-shaped space in the creation of hyperbolic dynamics and chaos. In our analogy, the spikes in the throat within a human host do not get transferred to the lungs because virologically spikes do not travel within the host but they grow over time under a no-treatment scenario. Only after treatment is initiated are the spikes in the throat killed and an equivalent number of newer spikes born to remain active for some time in the lungs. We imagine this phenomenon as described through Fig. 3.2 as the transformation of spikes of the throat to that of the lungs.
The geometry of the horseshoe is especially meaningful for us because spikes from the throat area due to the initial infected virus population are all located in one place. Then, due to the spread of the virus over the intervals , they diffuse into different organs which have geometrically a different shape than the throat. With the example of beads (Fig. 3.1), and assuming no scope for adding a new bead in the cube, the corresponding pipe would take the 2D horseshoe to a 3D similar-shaped pipe through discrete topology. Our spikes analogy is that the horseshoe example was built on 2D and diffusion of spikes within the human organs is imagined in 3D.
4. Discussion
Our study provides the most accurate mathematical structuring of the space of the SARS-CoV-2 virus and its spikes within the host. See the expression in section 2 and the clustering of spikes into bonded and unbonded spikes. The advantage of such a structure is to provide a detailed scope for mapping a spike that is available for bonding with an uninfected cell. Not a single unbonded spike will be left out in this process. The procedure also helps in tracking a bonded virus in such a way that the birth of newer virus particles through bonded spikes is monitored. See the expression , where , , and form three disjoint topological discrete subspaces mapped out from . The set emerges out of unbonded spikes in a previous time point and is the collection of spikes generated due to bonding spikes with cells at a previous time point. Our clear-cut visualization of the theoretical constructions helps in understanding the structure of the spike-cells within the space.
Laboratory experiments on the virus particles and bonding are usually done on a group of viruses. Our procedure provides deeper insight for better design in conducting experiments on isolated individual viruses. Such a method will help in aggregating the virus population along with their number of spikes and measuring bonded and unbonded spikes for each virus particle. Lemma 1 provides the growth of spikes and their mapping of initial spikes that can create newer spaces within a time interval.
One of the central features of our construction is the development of a new measure that we call “topological diffusion.” In general topology, no such measure exists. Using this measure, one can study the growth of spikes over time. The topological diffusion introduced in this article not only identifies the new spikes that emerge but how many of those were due to virus particles that had partial bonding of the spikes. These novel ideas make our work more practically implementable in pharmaceutical and vaccine industrial experiments. We have theoretically established this value within a small interval and also over a large interval. The descriptions of and are recorded in previous paragraphs and also in section 2. Fig. 2.3 provides an example of measuring the topological diffusion.
Theorem 6 provides the impact of a treatment in eliminating virus particles and Theorem 7 provides the impact of the vaccine on eliminating viruses after entry into a host. We also generalize our results over multiple time intervals and the timing of initiation of therapy. Topological diffusion constructed in the article is also associated with Stephen Smale's famous horseshoe type of example. The original example by Smale was constructed as a diffeomorphism of two open spaces, namely, a square and corresponding sized area of a horseshoe. However, the current article considered a transformation of a discrete collection of spikes in one organ of a human host into the equivalent number of spikes in a different organ. Moreover, the demonstration we provided was between two 3-D shaped organs within a human host. Such visualization of the horseshoe example is new in the literature.
5. Concluding remarks
The study presented in this paper is original and incisive. It uses powerful mathematical techniques—most notably ideas from topology—to analyze the bonding of corona virus cells. Our emphasis on discrete topology is somewhat novel.
As a result we obtain insights that will be useful in the production of new and more effective vaccines. We believe that the use of mathematical analysis in a medical context is a new and effective technique for epidemiology that will become recognized and solidly established in future work.
Acknowledgements
Comments by two referees helped to improve the exposition and to add one reference. We thank them all. No funding to declare for this study.
Submitted by J.J. Nieto
References
- 1.Bangaru S., et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science. 2021;370:1089–1094. doi: 10.1126/science.abe1502pmid:33082295. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Berger I., Schaffitzel C. The SARS-CoV-2 spike protein: balancing stability and infectivity. Cell Res. 2020;30:1059–1060. doi: 10.1038/s41422-020-00430-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Cai Y., Zhang J., Xiao T., Peng H., Sterling S.M., Walsh R.M., Jr., Rawson S., Rits-Volloch S., Chen B. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586–1592. doi: 10.1126/science.abd4251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Choe H., Farzan M. How SARS-CoV-2 first adapted in humans. Science. 2021;372(6541):466–467. doi: 10.1126/science.abi4711. [DOI] [PubMed] [Google Scholar]
- 5.Choi B., Choudhary MC Regan J., et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2031364. (published online Nov. 11) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dharma K., et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum. Vaccin. Immunother. 2020;16:1232–1238. doi: 10.1080/21645515.2020.1735227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Greaney A.J., et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. 2021;29(1):44–57.e9. doi: 10.1016/j.chom.2020.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Guruprasad L. Human SARS CoV-2 spike protein mutations. Proteins. 2021;89:569–576. doi: 10.1002/prot.26042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Herrera N.G., et al. Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis. ACS Omega. 2021;6(1):85–102. doi: 10.1021/acsomega.0c03512. Publication Date: December 21, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hoffmann M., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8. doi: 10.1016/j.cell.2020.02.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hussain M., Jabeen N., Raza F., et al. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J. Med. Virol. 2020;92:1580–1586. doi: 10.1002/jmv.25832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ismail S., Ahmad S., Azam S.S. Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine. J. Mol. Liq. 2020;314 doi: 10.1016/j.molliq.2020.113612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kar T., Narsaria U., Basak S., et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci. Rep. 2020;10 doi: 10.1038/s41598-020-67749-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586:516–527. doi: 10.1038/s41586-020-2798-3. [DOI] [PubMed] [Google Scholar]
- 15.Krantz S.G. CRC Press; Boca Raton, FL: 2010. Essentials of Topology with Applications. Textbooks in Mathematics. xvi+404 pp. [Google Scholar]
- 16.Liu C., et al. The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by Cryo-EM and Cryo-ET. Structure. 2021;28:1218–1224.e4. doi: 10.1016/j.str.2020.10.001pmid:33058760. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Liu Jia-Bao, Arockiaraj M., Arulperumjothi M., Prabhu S. Distance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19. Int. J. Quant. Chem. 2021;121(10) doi: 10.1002/qua.26617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Munkres James R. 2/e. Prentice Hall, Inc.; Upper Saddle River, NJ: 2000. Topology. xvi+537 pp. [Google Scholar]
- 19.Patra T., et al. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog. 2020 doi: 10.1371/journal.ppat.1009128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Petruk G., et al. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity. J. Mol. Cell Biol. 2020;12(12):916–932. doi: 10.1093/jmcb/mjaa067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ruelle D. What is … a strange attractor? Not. Am. Math. Soc. 2006;53(7):764–765. [Google Scholar]
- 22.Sakai K. Springer; Tokyo: 2013. Geometric Aspects of General Topology. (Springer Monographs in Mathematics). 978-4-431-54397-8, xvi+521 pp. [Google Scholar]
- 23.Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323:1824–1836. doi: 10.1001/jama.2020.6019. [DOI] [PubMed] [Google Scholar]
- 24.Shub M. What is a horseshoe? Not. Am. Math. Soc. 2005;52:530–532. [Google Scholar]
- 25.Singh T.B. Springer; Singapore: 2019. Introduction to Topology. 978-981-13-6954-4, xix+452 pp. [Google Scholar]
- 26.Smale S. Differentiable dynamical systems. Bull. Am. Math. Soc. 1967;73:747–817. [Google Scholar]
- 27.Smale S. Finding a horseshoe on the beaches of Rio. Math. Intell. 1998;20:39–44. [Google Scholar]
- 28.Srivastava S., et al. Computationally validated SARS-CoV-2 CTL and HTL multi-patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide. J. Biomol. Struct. Dyn. 2020;DOI doi: 10.1080/07391102.2020.1838329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Walls A.C., et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. 2020. https://doi.org/10.1016/j.cell.2020.02.058 Cell. [DOI] [PMC free article] [PubMed]
- 30.Watanabe Y., et al. Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine. ACS Cent. Sci. 2021 doi: 10.1021/acscentsci.1c00080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zhang Huilan, Zhou Peng, Wei Yanqiu, et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann. Intern. Med. 2020;172:629–632. doi: 10.7326/M20-0533. [Epub ahead of print 12 March 2020] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhang J., et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science. 2021;372(6541):525–530. doi: 10.1126/science.abf2303. [DOI] [PMC free article] [PubMed] [Google Scholar]